Holmes Biopharma, Inc. (LMB) Misses Q1 EPS by 65c, Slight Beat on Revenues; Boosts FY19 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Limbach Holdings Reports First Quarter 2018 Results
May 15, 2018 4:15 PM EDTQ1 2018 Revenues of $120.5 Million; Construction Revenues of $96.8 Million
Conference Call Scheduled for 9:00am ET Wednesday May 16, 2018
PITTSBURGH--(BUSINESS WIRE)-- Limbach Holdings, Inc. (NASDAQ: LMB) (Limbach or the Company) today announced financial results for the quarter ended March 31, 2018. Total revenues increased 4.7% versus the prior year period to $120.5 million in the first quarter of 2018. Construction segment revenue of $96.8 million grew 5.8% from the prior year period while Service segment revenues were flat at $23.7 million.
Other key financial highlights of the quarter included:
... More